These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 9764787)

  • 1. Taste and smell complaints in HIV-infected patients.
    Heald AE; Pieper CF; Schiffman SS
    AIDS; 1998 Sep; 12(13):1667-74. PubMed ID: 9764787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the nucleoside analogs zidovudine, didanosine, stavudine, and lamivudine on the sense of taste.
    Schiffman SS; Zervakis J; Shaio E; Heald AE
    Nutrition; 1999; 15(11-12):854-9. PubMed ID: 10575660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemosensory dysfunction is a primary factor in the evolution of declining nutritional status and quality of life in patients with advanced cancer.
    Hutton JL; Baracos VE; Wismer WV
    J Pain Symptom Manage; 2007 Feb; 33(2):156-65. PubMed ID: 17280921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II).
    Eron JJ; Murphy RL; Peterson D; Pottage J; Parenti DM; Jemsek J; Swindells S; Sepulveda G; Bellos N; Rashbaum BC; Esinhart J; Schoellkopf N; Grosso R; Stevens M
    AIDS; 2000 Jul; 14(11):1601-10. PubMed ID: 10983647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemosensory function and diet in HIV-infected patients.
    Mattes RD; Wysocki CJ; Graziani A; MacGregor RR
    Laryngoscope; 1995 Aug; 105(8 Pt 1):862-6. PubMed ID: 7630301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
    Hammer SM; Squires KE; Hughes MD; Grimes JM; Demeter LM; Currier JS; Eron JJ; Feinberg JE; Balfour HH; Deyton LR; Chodakewitz JA; Fischl MA
    N Engl J Med; 1997 Sep; 337(11):725-33. PubMed ID: 9287227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of zidovudine plus lamivudine or zalcitabine on health-related quality of life.
    Scott-Lennox JA; Mills RJ; Burt MS
    Ann Pharmacother; 1998 May; 32(5):525-30. PubMed ID: 9606471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
    AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity of antiretroviral agents.
    Struble KA; Pratt RD; Gitterman SR
    Am J Med; 1997 May; 102(5B):65-7; discussion 68-9. PubMed ID: 9845500
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemosensory changes experienced by patients undergoing cancer chemotherapy: a qualitative interview study.
    Bernhardson BM; Tishelman C; Rutqvist LE
    J Pain Symptom Manage; 2007 Oct; 34(4):403-12. PubMed ID: 17616338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005).
    Boyd MA; Srasuebkul P; Khongphattanayothin M; Ruxrungtham K; Hassink EA; Duncombe CJ; Ubolyam S; Burger DM; Reiss P; Stek M; Lange J; Cooper DA; Phanuphak P
    Antivir Ther; 2006; 11(2):223-32. PubMed ID: 16640103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine.
    Gulick RM; Meibohm A; Havlir D; Eron JJ; Mosley A; Chodakewitz JA; Isaacs R; Gonzalez C; McMahon D; Richman DD; Robertson M; Mellors JW
    AIDS; 2003 Nov; 17(16):2345-9. PubMed ID: 14571186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing taste and smell alterations in cancer patients undergoing chemotherapy according to treatment.
    Amézaga J; Alfaro B; Ríos Y; Larraioz A; Ugartemendia G; Urruticoechea A; Tueros I
    Support Care Cancer; 2018 Dec; 26(12):4077-4086. PubMed ID: 29855774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taste and smell losses in HIV infected patients.
    Graham CS; Graham BG; Bartlett JA; Heald AE; Schiffman SS
    Physiol Behav; 1995 Aug; 58(2):287-93. PubMed ID: 7568432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine.
    Coplan PM; Cook JR; Carides GW; Heyse JF; Wu AW; Hammer SM; Nguyen BY; Meibohm AR; DiNubile MJ;
    Clin Infect Dis; 2004 Aug; 39(3):426-33. PubMed ID: 15307012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine.
    Gulick RM; Mellors JW; Havlir D; Eron JJ; Meibohm A; Condra JH; Valentine FT; McMahon D; Gonzalez C; Jonas L; Emini EA; Chodakewitz JA; Isaacs R; Richman DD
    Ann Intern Med; 2000 Jul; 133(1):35-9. PubMed ID: 10877738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of lipoatrophy under stavudine in HIV-1-infected patients: results of a substudy from a comparative trial.
    Joly V; Flandre P; Meiffredy V; Leturque N; Harel M; Aboulker JP; Yeni P
    AIDS; 2002 Dec; 16(18):2447-54. PubMed ID: 12461419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life in HIV patients switching to twice-daily indinavir/ritonavir regimen or continuing with three-times-daily indinavir-based therapy.
    Badía X; Podzamczer D; Moral I; Roset M; Arnaiz JA; Loncà M; Casiró A; Rosón B; Gatell JM;
    Antivir Ther; 2004 Dec; 9(6):979-85. PubMed ID: 15651756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A ChemoSensory questionnaire for patients treated for cancer of the head and neck.
    Goldberg AN; Shea JA; Deems DA; Doty RL
    Laryngoscope; 2005 Dec; 115(12):2077-86. PubMed ID: 16369148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smell and taste disorders, a study of 750 patients from the University of Pennsylvania Smell and Taste Center.
    Deems DA; Doty RL; Settle RG; Moore-Gillon V; Shaman P; Mester AF; Kimmelman CP; Brightman VJ; Snow JB
    Arch Otolaryngol Head Neck Surg; 1991 May; 117(5):519-28. PubMed ID: 2021470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.